Squarepoint Ops LLC Paratek Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.7 - $7.24 $58,308 - $89,819	-12,406 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.81 - $10.93 $84,484 - $135,597	12,406 New	12,406 $85,000
Q4 2020 Feb 16, 2021	SELL	$4.58 - $7.14 $142,836 - $222,675	-31,187 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$4.19 - $6.69 $398,728 - $636,633	-95,162 Reduced 75.32%	31,187 $169,000
Q2 2020 Aug 14, 2020	BUY	$2.97 - $5.22 $375,256 - $659,541	126,349 New	126,349 $660,000
Q1 2020 May 15, 2020	SELL	$2.67 - $4.97 $68,114 - $126,789	-25,511 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.93 - $4.5 $74,747 - $114,799	25,511 New	25,511 $103,000
Q4 2018 Feb 14, 2019	SELL	$4.8 - $11.6 $49,665 - $120,025	-10,347 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$9.05 - $10.95 $93,640 - $113,299	10,347 New	10,347 $100,000
Q2 2018 Aug 14, 2018	SELL	$10.2 - $13.9 $159,120 - $216,840	-15,600 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$12.65 - $18.85 $183,703 - $273,739	-14,522 Reduced 48.21%	15,600 $203,000
Q4 2017 Feb 14, 2018	BUY	$17.45 - $25.6 $525,628 - $771,123	30,122	30,122 $539,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.